At 593 Days/~20 Months (N=40): Total 25.4 kg reduction from baseline (99.5 kg to 74.1 kg), BMI improved by 9.3 kg/m (from 36.5 to 27.2 kg/m), achieving 25.5% 2.4% total weight loss maintained entirely on generic AOMs without GLP-1 RA therapy
A number of small clinical trials have shown promising results for NAC administration in another disorder with sensory gating issues, Autism Spectrum Disorder (ASD) (Hardan et al, 2012)
Anyone with a personal or family history of medullary thyroid cancer, thyroid nodules, MEN2, or unexplained neck swelling should speak to a healthcare professional and avoid unregulated products sold online
Trial data shows significant weight loss for both, but the studies were conducted separately with different patient populations and timeframes
In the realm of connective tissue disorders, genetic studies have definitively linked L-Lysine processing to collagen stability
Treatment should be discontinued if patients have not lost at least 5% of their initial body weight after 12 weeks at the maintenance dose